Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Polycythemia Vera | Proteins and Peptides | News Channels PipelineReview.com
from "phlebotomy" - Google News http://bit.ly/2N08VBe
No comments:
Post a Comment